Press enter to begin your search

ValiRx - Extension of Collaboration Agreement

VAL
Mon, 15 Feb 2021, 12:00pm GMT

Dr Suzy Dilly, Chief Executive Officer, discusses the recently announced agreement with Physiomics plc. ValiRx is pleased to be able to expand their collaboration and the scope of work being carried out by Physiomics.

Suzanne Dilly
Chief Executive Officer
VAL
602a52921fc46330548f9b04
SHOW MORE
FROM THIS COMPANY
ValiRx - Extension of Collaboration Agreement
VAL Mon, 15 Feb 2021, 12:00pm GMT

ValiRx Plc is a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision medicines towards commercialisation and partnering

Industry: Health Care

Contact:

http://www.valirx.com/

Dr Suzy Dilly, Chief Executive Officer, discusses the recently announced agreement with Physiomics plc. ValiRx is pleased to be able to expand their collaboration and the scope of work being carried out by Physiomics.

Suzanne Dilly
Chief Executive Officer
POWERED BY